France· FR:63197002
APREXEVO 150 mg/10 mg, comprimé pelliculé
A medicinal product containing irbésartan + bésilate d'amlodipine, registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IRBÉSARTAN + BÉSILATE D'AMLODIPINE
- Manufacturer
- SANOFI WINTHROP INDUSTRIE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400930207673plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)EUR 6.39
- cip133400930207680plaquette(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)EUR 19.04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Irbésartan + bésilate d'amlodipine in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Cyprus · Combipress
- Spain · Aproxxamlo
- Greece · Aproxxamlo, Combipress
- Italy · Aproxxamlo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb71d278-ce32-4e2e-8a9b-4c1423d2a1b8 GET /v1/drugs/cb71d278-ce32-4e2e-8a9b-4c1423d2a1b8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63197002",
"date_amm": "2020-05-14",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "IRBÉSARTAN + BÉSILATE D'AMLODIPINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about irbésartan + bésilate d'amlodipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.